<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01710436</url>
  </required_header>
  <id_info>
    <org_study_id>RDPAC2012</org_study_id>
    <nct_id>NCT01710436</nct_id>
  </id_info>
  <brief_title>Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype</brief_title>
  <acronym>RDPAC</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, observational study to estimate the relationship between dosage
      of clopidogrel and platelet aggregation in Chinese with different genotype. The investigators
      suppose both pretreatment dosage of clopidogrel before percutaneous coronary intervention
      (PCI) and CYP2C19 genotype may effect the platelet aggregation as well as clinical outcome.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in platelet aggregation</measure>
    <time_frame>1 month and 6 months after PCI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events (MACE); Bleeding events</measure>
    <time_frame>6 months after PCI</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">880</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Low dose - Wild genotype (LW)</arm_group_label>
    <description>75mg Qd &gt; 7d Clopidogrel pre-treatment before PCI, according to the reality; CYP2C19 wild genotype</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose - Variant genotype (LV)</arm_group_label>
    <description>75mg Qd &gt; 7d Clopidogrel pre-treatment before PCI, according to the reality; CYP2C19 variant genotype</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose - Wild genotype (HW)</arm_group_label>
    <description>300mg Clopidogrel loading dose pre-treatment before PCI, according to the reality; CYP2C19 wild genotype</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose - Variant genotype (HV)</arm_group_label>
    <description>300mg Clopidogrel loading dose pre-treatment before PCI, according to the reality; CYP2C19 variant genotype</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese coronary heart disease (CHD) patient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  accept PCI in Chinese CHD patients

          -  expected dual antiplatelet therapy (DAPT) at least 6 months

        Exclusion Criteria:

          -  another planned PCI within 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiovascular Institute and Fu Wai Hospital, CAMS &amp; PUMC</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2012</study_first_submitted>
  <study_first_submitted_qc>October 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2012</study_first_posted>
  <last_update_submitted>May 16, 2013</last_update_submitted>
  <last_update_submitted_qc>May 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Xiaoxing Zhang</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

